The first quantitative histomorphological analyses of bone vitality and inflammation in surgical specimens of patients with medication-related osteonecrosis of the jaw

被引:4
|
作者
Mamilos, Andreas [1 ]
Spoerl, Steffen [2 ]
Spanier, Gerrit [2 ]
Ettl, Tobias [2 ]
Brochhausen, Christoph [1 ]
Klingelhoeffer, Christoph [2 ]
机构
[1] Univ Regensburg, Dept Pathol, Regensburg, Germany
[2] Univ Hosp Regensburg, Dept Craniomaxillofacial Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany
关键词
histopathology; inflammation; regeneration; medication-related osteonecrosis of the jaw; surgery; BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; RISK-FACTORS; MANAGEMENT; CANCER; DENOSUMAB;
D O I
10.1111/jop.13112
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background The purpose of the study was to categorize the vitality and inflammation of resected bone of patients with medication-related osteonecrosis of the jaw (MRONJ) and to correlate the grade of inflammation with the surgical success. Methods This prospective study includes 44 patients with stage III MRONJ. Necrotic bone was resected in a block fashioned way. After demineralization and staining, histological analyses were performed by measuring the areas of necrotic, vital, and regenerative bone. Areas of chronic and acute inflammation were categorized as non, mild, moderate, and severe and were correlated with surgical success and parameters of inflammation in blood plasma (C-reactive protein and leukocytes). Results An average area of 59.0% was necrotic in the examined specimen. Vital bone was measured with an average area of 40.9%. The stage of chronic inflammation correlated with the amount of vital bone (P < .001) and the success of surgery (P = .002). If acute inflammation was dominant, chronic inflammation areas were found less while necrotic areas were observed more (P < .001). Also, the risk of relapses, wound healing disorders, and the level of C-reactive protein were elevated if acute inflammation was severe or moderate (P = .031). Areas of bone regeneration were seen only in 11.3% of vital bone areas and occurred independently of infection stages. Conclusion If possible, surgery should be delayed in patients with signs of severe acute inflammation. Patients may profit from prolonged pre-operative antibiotic therapy to reduce the level of acute inflammation.
引用
收藏
页码:76 / 84
页数:9
相关论文
共 50 条
  • [31] Autologous platelet concentrates as adjuvant in the surgical management of medication-related osteonecrosis of the jaw
    Bennardo, Francesco
    Barone, Selene
    Antonelli, Alessandro
    Giudice, Amerigo
    PERIODONTOLOGY 2000, 2025, 97 (01) : 287 - 307
  • [32] Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis
    Kang, Sang-Hoon
    Won, Yu-Jin
    Kim, Moon-Key
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2018, 36 (06): : 373 - 380
  • [33] Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease
    Kim, Jin-Woo
    Tatad, Jacquiline Czar I.
    Landayan, Maria Erika A.
    Kim, Sun-Jong
    Kim, Myung-Rae
    BONE, 2015, 81 : 442 - 448
  • [34] Medication-related osteonecrosis of the upper jaw involving the zygomatic bone: A case report
    Otsuru, Mitsunobu
    Soutome, Sakiko
    Hayashida, Saki
    Morishita, Kota
    Yanamoto, Souichi
    Umeda, Masahiro
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2023, 104
  • [35] Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients
    Tempesta, Angela
    Capodiferro, Saverio
    Di Nanna, Simona
    D'Agostino, Silvia
    Dolci, Marco
    Scarano, Antonio
    Gambarini, Gianluca
    Maiorano, Eugenio
    Favia, Gianfranco
    Limongelli, Luisa
    ORAL DISEASES, 2023, 29 (07) : 2799 - 2805
  • [36] Medication-related osteonecrosis of the jaw: A disease of significant importance for older patients
    Boston, Bridget
    Ipe, Deepak
    Capitanescu, Bogdan
    Gresita, Andrei
    Hamlet, Stephen
    Love, Robert
    Hadjiargyrou, Michael
    Huang, Chien-Ling
    Nusem, Iulian
    Miroiu, Rodica Ileana
    Popa-Wagner, Aurel
    Warnke, Patrick Hans-Heinrich
    Petcu, Eugen Bogdan
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (08) : 2640 - 2652
  • [37] COMMENT ON: MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROTIC PATIENTS: PREVENTION AND MANAGEMENT
    Toh, Choon Lai
    Dutton, Andrew
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (05) : 287 - 287
  • [38] Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw
    Sara de Cassia Tornier
    Fernanda Joly Macedo
    Laurindo Moacir Sassi
    Juliana Lucena Schussel
    Supportive Care in Cancer, 2021, 29 : 6713 - 6719
  • [39] Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw
    de Cassia Tornier, Sara
    Macedo, Fernanda Joly
    Sassi, Laurindo Moacir
    Schussel, Juliana Lucena
    SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6713 - 6719
  • [40] Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw
    Colapinto, Gianluca
    Volpi, Raffaele
    Forino, Giovanni
    Tricarico, Vito
    De Benedittis, Michele
    Cortelazzi, Roberto
    Testori, Tiziano
    Del Fabbro, Massimo
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2018, 125 (02): : 147 - 156